Prenatal genetic testing 2: diagnostic tests.
Journal
Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
pubmed:
10
9
2022
medline:
4
11
2022
entrez:
9
9
2022
Statut:
ppublish
Résumé
Prenatal genetic testing can be divided into two categories: screening and diagnosis. Prenatal genetic screening tests are used to assess carrier status or as a fetal risk assessment for a particular genetic disorder [1]. Prenatal genetic diagnostic testing is used to diagnose particular genetic conditions with as much certainty as possible [1,2]. This review will focus on the diagnostic side of prenatal genetic testing. Next generation sequencing (NGS) has revolutionized prenatal genetic diagnostic testing. NGS methods are becoming more advanced and accurate as more genetic information is being linked to genetic conditions. Prenatal genetic diagnostic testing involves clinicians invasively obtaining tissue via amniocentesis or chorionic villus sampling to identify if a fetus has a genetic condition. This testing has traditionally been done through fluorescence in-situ hybridization, karyotype, or chromosomal microarray analysis. However, genetic testing is in a time of rapid technologic expansion and new methods like NGS, which includes targeted gene panels, whole exome sequencing, and whole genome sequencing are being used too. In this time of growth, it is important that providers educate themselves on the research support and indication behind each type of genetic diagnostic test.
Identifiants
pubmed: 36081360
doi: 10.1097/MOP.0000000000001174
pii: 00008480-202212000-00006
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
553-558Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Practice bulletin no. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol 2016; 127:e108–e122.
Carlson L, Vora N. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin North Am 2017; 44:245–256.
Kochanek K, Kirmeyer S, Martin J, et al. Annual summary of vital statistics: 2009. Pediatrics 2012; 129:338–348.
Amniocentesis. Mayo Foundation for Medical Education and Research. n.d. Retrieved June 14, 2022, from https://www.mayoclinic.org/tests-procedures/amniocentesis/about/pac-20392914
Chorionic Villus Sampling. Mayo Foundation for Medical Education and Research. Mayo Clinic 2020. Retrieved June 14, 2022, from https://www.mayoclinic.org/tests-procedures/chorionic-villus-sampling/about/pac-20393533
Grati F, Malvestiti F, Ferreira J, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014; 16:620–624.
Jackson L, Zachary J, Fowler S, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 1992; 327:594–598.
Weise A, Liehr T. Rapid prenatal aneuploidy screening by fluorescence in situ hybridization (FISH). Methods Mol Biol 2008; 444:39–47.
Dugoff L, Norton M, Kuller J. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol 2016; 215:B2–B9.
Behjati S, Tarpey P. What is next generation sequencing? Arch Dis Child Educ Pract Ed 2013; 98:236–238.
Zhou X, Chandler N, Deng L, et al. Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel. Prenat Diagn 2018; 38:692–699.
Manickam K, McClain M, Demmer L, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23:2029–2037.
Tolusso L, Hazelton P, Wong B, Swarr D. Beyond diagnostic yield: prenatal exome sequencing results in maternal, neonatal, and familial clinical management changes. Genet Med 2021; 23:909–917.
Joint position statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis. Prenat Diagn 2018; 38:6–9.
Edwards J, Feldman G, Goldberg J, et al. Expanded carrier screening in reproductive medicine—points to consider. Obstet Gynecol 2015; 125:653–662.